Rhodes Jason P
SEC CIK 1577014 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | Dir | 428.9K | $10.00M | $173.35M | 15 | 2022-12-12 | 2026-08-13 |
Most active insiders at DYN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rhodes Jason P | Dir | — | $129.10M |
| 2 | Kersten Dirk | Dir | — | $38.57M |
| 3 | Cox John | CEO, Pres, Dir | — | $443.7K |
| 4 | Posner Brian S | Dir | $274.8K | — |
| 5 | Kerr Douglas | Chief Medical Off | — | $233.1K |
| 6 | Lucera Erick | CFO | — | $228.7K |
| 7 | Friedl-Naderer Johanna | Chief Commercial Off | — | $43.4K |
| 8 | Lubner David Charles | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MTI | 2026-08-17 17:30 | 2026-08-13+ | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $25.20 | -2.59M | 428.9K | -86% | -$65.18M |
| MTI | 2026-07-08 17:35 | 2026-07-06+ | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $22.97 | -777.5K | 2,962 | -100% | -$17.86M |
| MTI | 2026-06-30 19:05 | 2026-06-26+ | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $21.23 | -504.7K | 975.9K | -34% | -$10.71M |
| MTI | 2026-06-26 08:40 | 2026-06-23+ | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $21.09 | -267.8K | 1.08M | -20% | -$5.65M |
| MTI | 2026-05-06 17:09 | 2026-05-04+ | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $18.14 | -106.7K | 1.14M | -9% | -$1.94M |
| MTI | 2026-04-30 17:22 | 2026-04-28 | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $18.38 | -227.3K | 1.16M | -16% | -$4.18M |
| MTI | 2026-04-27 18:15 | 2026-04-23+ | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $18.47 | -384.5K | 1.21M | -24% | -$7.10M |
| MTI | 2026-04-22 18:27 | 2026-04-20+ | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $19.75 | -834.3K | 1.29M | -39% | -$16.48M |
| I | 2025-01-29 | 2025-01-27 | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | A - Grant | $13.50 | +1.11M | 1.96M | +131% | +$15.00M |
| MI | 2024-11-18 | 2024-11-14 | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $33.10 | -782 | 847.3K | -0.1% | -$25.9K |
| MI | 2024-03-05 | 2024-03-01 | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $30.05 | -46.5K | 1.46M | -3% | -$1.40M |
| MI | 2024-02-28 | 2024-02-26+ | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $24.30 | -807.8K | 880.0K | -48% | -$19.63M |
| MI | 2024-02-23 | 2024-02-21+ | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $22.64 | -500.8K | 6.35M | -7% | -$11.34M |
| MI | 2024-02-20 | 2024-02-15+ | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | S - Sale | $23.26 | -510.2K | 7.15M | -7% | -$11.87M |
| I | 2022-12-14 | 2022-12-12 | DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Dir | P - Purchase | $10.70 | +934.6K | 934.6K | New | +$10.00M |
Purchase Sale Sale after option exercise All abbreviations